Ribosomally synthesized and posttranslationally modified
peptides
(RiPPs) with polar-functionalized fatty acyl groups are a rarely found
untapped class of natural products. Although polar-functionalized
fatty-acylated RiPPs (PFARs) have potential as antimicrobial agents,
the repertoire is still limited. Therefore, expanding the chemical
space is expected to contribute to the development of pharmaceutical
agents. In this study, we performed genome mining and stable isotope-guided
comparative metabolomics to discover new PFAR natural products. We
focused on the feature that PFARs incorporate l-arginine
or l-lysine as the starter unit of the fatty acyl group and
fed 13C6,15N4-l-arginine or 13C6,15N2-l-lysine to bacterial cultures. Metabolites were extracted
and compared with those extracted from nonlabeled l-arginine
or l-lysine fed cultures. We identified putative PFARs and
successfully isolated solabiomycin A and B from Streptomyces
lydicus NBRC 13 058 and albopeptin B from Streptomyces nigrescens HEK616, which contained a
sulfoxide group in the labionin moiety. The gene disruption experiment
indicated that solS, which encodes a putative flavin
adenine dinucleotide (FAD)–nicotinamide adenine dinucleotide
(phosphate) (NAD(P))-binding protein, is involved in the sulfoxidation
of aryl sulfides. The solabiomycins showed antibacterial activity
against Gram-positive bacteria, including Mycobacterium
tuberculosis H37Rv with a minimum 95% inhibitory concentration
(MIC95) of 3.125 μg/mL, suggesting their potential
as antituberculosis agents.